Stay updated on Durvalumab in Resectable Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab in Resectable Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab in Resectable Lung Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.
    Difference
    1.0%
    Check dated 2025-04-22T17:59:18.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4 and has removed the date 2025-03-25 while adding the date 2025-01-14.
    Difference
    1.0%
    Check dated 2025-04-08T09:09:04.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    56 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-03-03T13:59:38.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    6%
    Check dated 2025-02-10T08:51:47.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T02:11:30.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    The website has been updated to version 2.14.1 on January 14, 2025, following the removal of version 2.14.0 on August 22, 2024.
    Difference
    1%
    Check dated 2025-01-19T12:11:45.000Z thumbnail image

Stay in the know with updates to Durvalumab in Resectable Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab in Resectable Lung Cancer Clinical Trial page.